COMBINED THERAPY WITH DONEPEZIL AND MEMANTINE IN THE TREATMENT OF MODERATE TO SEVERE ALZHEIMER'S DISEASE
DOI:
https://doi.org/10.56238/levv17n59-006Keywords:
Alzheimer’s Disease, Donepezil, Memantine, Combination Therapy, DementiaAbstract
Alzheimer’s disease is a progressive neurodegenerative disorder characterized by cognitive, behavioral, and functional decline, particularly in moderate to severe stages. In this context, combination therapy with donepezil, an acetylcholinesterase inhibitor, and memantine, an NMDA receptor antagonist, has been proposed as a therapeutic strategy to enhance clinical outcomes. This study aims to analyze the efficacy and safety of this combination in the treatment of moderate to severe Alzheimer’s disease. This is an integrative literature review with a qualitative and descriptive approach, based on studies retrieved from PubMed, SciELO, LILACS, covering publications from 2016 to 2026. The findings indicate that combination therapy provides superior benefits compared to monotherapy in terms of cognition, daily functioning, and behavioral symptoms, although clinical gains are generally modest. A favorable safety profile and potential cost-effectiveness were also observed, particularly in public healthcare settings. It is concluded that the association of donepezil and memantine is a valid therapeutic option, and its use should be individualized according to patient clinical characteristics.
Downloads
References
CARAMELLI, Paulo et al. Tratamento da demência: recomendações do Departamento Científico de Neurologia Cognitiva e do Envelhecimento da Academia Brasileira de Neurologia. Dementia & Neuropsychologia, v. 16, p. 88-100, 2022.
COSTA, Ray de Lima Coutinho et al. Perspectivas atuais da doença de Alzheimer: aspectos patogênicos e terapêuticos. Brazilian Journal of Implantology and Health Sciences, v. 6, n. 5, p. 1500-1511, 2024.
DE AZEVEDO FILHO, Francino Machado et al. Análises econômicas da donepezila isolada ou em combinação à memantina para tratamento de pacientes com doença de Alzheimer grave no SUS. Epidemiologia e Serviços de Saúde, v. 34, supl. 1, p. 50, 2025.
FEITOZA, Davi et al. Avaliação dos diferentes tipos de tratamento farmacológico da doença de Alzheimer: revisão integrativa. Revista Coopex, v. 15, n. 2, p. 5035-5050, 2024.
KUMAR, Anil; GUPTA, Vikas; SHARMA, Sandeep. Donepezil. In: STATPEARLS [Internet]. Treasure Island: StatPearls Publishing, 2023.
LEIRAS, Rita Margarida Valadas. Farmacogenética aplicada ao tratamento da doença de Alzheimer. 2016. Dissertação (Mestrado) – Egas Moniz School of Health and Science, Portugal, 2016.
LEMOS, Andressa Lizzy Ferreira et al. Uso da memantina na evolução da doença de Alzheimer: uma revisão integrativa. Caderno Pedagógico, v. 21, n. 6, p. e5127, 2024.
NETO, Ana Clara Câmara; QUEIROZ SALEK, João Miranda; ALMEIDA MAROÑAS, Patricia. Comparação entre antagonistas dos receptores NMDA e anticolinesterásicos no tratamento da doença de Alzheimer: uma revisão de literatura. ACTA MSM, v. 12, n. 1, p. 135-143, 2025.
OLIVEIRA, Gunaro Lucas dos Santos de et al. Combined therapy for Alzheimer's disease and mild cognitive impairment: a systematic review of randomized clinical trials. Dementia & Neuropsychologia, v. 20, 2026. DOI: 10.1590/1980-5764-dn-2025-0346
OLIVEIRA, Ione Ayala Gualandi de et al. Revisão sistemática de avaliações econômicas acerca do uso da memantina isolada ou combinada com o donepezil para a doença de Alzheimer moderada a grave. Revista Brasileira de Geriatria e Gerontologia, v. 22, p. e190002, 2019.
ROSADO, Rita Montalto. Avanços terapêuticos na doença de Alzheimer. 2021. Dissertação (Mestrado) – Universidade de Lisboa, Portugal, 2021.
SHIN, Chang Yell et al. The effects of donepezil, an acetylcholinesterase inhibitor, on impaired learning and memory in rodents. Biomolecules & Therapeutics, v. 26, n. 3, p. 274, 2018.
SILVEIRA SALES E SILVA, Anna Clara et al. Impactos na progressão da doença de Alzheimer sob tratamento farmacológico. Revista Foco, v. 17, n. 4, p. e4904, 2024.
SOBRAL, Maria Fernanda Barbosa et al. Abordagens terapêuticas emergentes para o tratamento da doença de Alzheimer. Revista Contemporânea, v. 4, n. 5, p. e4296, 2024.
UNZETA, Mercedes et al. Multi-target directed donepezil-like ligands for Alzheimer's disease. Frontiers in Neuroscience, v. 10, p. 205, 2016.
BIRKS, Jacqueline S.; HARVEY, Richard J. Donepezil for dementia due to Alzheimer's disease. Cochrane Database of Systematic Reviews, n. 6, 2018.
